CTRI/2024/03/064841尚未招募2 期
Randomized, open-label, pilot clinical trial to evaluate the efficacy of Saindhavadi Anjana in Meibomian Gland Dysfunction (MGD) associated Dry Eye Disease (DED) - Nil
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- one
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Signed ICF (Informed Consent Form)
- •Patients presenting with signs and symptoms of Shushkakshipaka
- •Patients presenting with signs of MGD
- •Ocular dryness
- •Meibomian gland orifice plugging
- •Lid margin telangiectasia
- •TBUT less than 5 seconds
- •Schirmer’s test less than 10mm
排除标准
- •Cases complicated with acute, chronic, infective conjunctivitis or any specific eyelid disorder, corneal ulcer, dacryocystitis and lagophthalmos
- •Inflammatory diseases unrelated to MGD
- •Patients suffering from any systemic disorder or taking any medications which in the
- •opinion of PI may affect the clinical outcome of the trial
- •Contact lenses use
- •History of ocular surgery within 6 months prior to enrolment in trial
- •Pregnancy or child bearing age without contraception
- •Stevens-Johnson syndrome
- •Chemical, thermal or radiation injury
- •Sjogren’s syndrome
- •Patient who starts developing complications will be excluded from the study
- •Patient not willing for the treatment
- •Ongoing ocular or systemic infection
- •Ocular or periocular malignancy
- •Use of topical steroids, topical cyclosporine, topical anti-glaucoma medication within 60 days before screening
- •Lid structural abnormality not caused by MGD
研究者
相似试验
招募中
2 期
Carvedilol as a single-drug therapy for Heart Failure with recovered ejection fraction: an open label randomized clinical trialeft-side heart failureI50RBR-75jm4cjInstituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
进行中（未招募）
不适用
A pilot, open label, randomised clinical trial assessing the 12 week immunological response in HIV-1 failing subjects receiving monotherapy with emtricitabine 200 mg once a day or emtricitabine 200 mg once a week or lamivudine 300 mg once a day - The Break StudyHIV-InfectionMedDRA version: 6.1Level: PTClassification code 10000565EUCTR2006-001681-16-ITFONDAZIONE NADIR ONLUS60
招募中
4 期
Intravitreal Aflibercept for the Treatment of Treatment Resistant Macular Oedema secondary to Retinal Vein Occlusionsmacular oedema secondary to retinal vein occlusionACTRN12617001487303A/Prof Andrew Chang50
尚未招募
1 期
Clinical evaluation of custom-made bracketsmalocclusionJPRN-jRCTs022230061Kanetaka Hiroyasu26
尚未招募
不适用
An open-label, prospective randomized trial to assess the non-inferiority of diuretic effect of tolvaptan as an alternative agent to loop diuretics in chronic heart failure.chronic heart failureJPRN-UMIN000026331Department of Cardio-Renal Medicine and Hypertension, Graduate School of Medical Sciences, Nagoya City University, Japan200